Literature DB >> 25386822

Involvement of cysteine proteases in cancer.

Jerzy Góra, Rafal Latajka1.   

Abstract

The cysteine protease family members play important roles in various pivotal cellular processes. The difficulty in the analysis of the effects of cysteine protease aberrations in cancer comes as a result of the fact that they take part in complex proteolytic pathways. Nevertheless, there is a vast amount of data regarding the involvement of distinct members of this family in divergent types of cancer. Cysteine proteases assist migration and development of the disease, as well as increase the invasiveness of particular kinds of tumors. They are designated as both drug targets, as well as cancer susceptibility biomarkers. This implies that the abnormalities in their activity and expression patterns may be associated with the hallmarks of cancer. This review demonstrates that the influence of cysteine proteases on different mechanisms underlying cancer is undisputable. Thus, they are potent targets for future study and should be recognized as key players in the fight against cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25386822     DOI: 10.2174/0929867321666141106115624

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  Inhibition of Cathepsin K: A Novel and Promising Treatment for Osteoporosis.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-05-13       Impact factor: 4.345

2.  Suppression of calpain expression by NSAIDs is associated with inhibition of cell migration in rat duodenum.

Authors:  Kristopher Silver; A Littlejohn; Laurel Thomas; Bhupinder Bawa; James D Lillich
Journal:  Toxicology       Date:  2017-03-22       Impact factor: 4.221

3.  Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.

Authors:  Haitao Luan; Bhopal Mohapatra; Timothy A Bielecki; Insha Mushtaq; Sameer Mirza; Tameka A Jennings; Robert J Clubb; Wei An; Dena Ahmed; Rokaya El-Ansari; Matthew D Storck; Nitish K Mishra; Chittibabu Guda; Yuri M Sheinin; Jane L Meza; Srikumar Raja; Emad A Rakha; Vimla Band; Hamid Band
Journal:  Cancer Res       Date:  2018-03-06       Impact factor: 12.701

4.  Fibronectin induces epithelial-mesenchymal transition in human breast cancer MCF-7 cells via activation of calpain.

Authors:  Cheng-Lin Li; Dan Yang; Xin Cao; Fan Wang; Duan-Yang Hong; Jing Wang; Xiang-Chun Shen; Yan Chen
Journal:  Oncol Lett       Date:  2017-03-23       Impact factor: 2.967

5.  Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.

Authors:  Marie K Malone; Karly Smrekar; Sunju Park; Brianna Blakely; Alec Walter; Nicholas Nasta; Jay Park; Michael Considine; Ludmila V Danilova; Niranjan B Pandey; Elana J Fertig; Aleksander S Popel; Kideok Jin
Journal:  Cancer Biol Ther       Date:  2020-03-26       Impact factor: 4.742

6.  LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells.

Authors:  Yan Yan; Qingxia Fan; Liping Wang; Yue Zhou; Jianhua Li; Kun Zhou
Journal:  Oncotarget       Date:  2017-05-30

Review 7.  Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development.

Authors:  Agnieszka Staśkiewicz; Patrycja Ledwoń; Paolo Rovero; Anna Maria Papini; Rafal Latajka
Journal:  Front Chem       Date:  2021-05-20       Impact factor: 5.221

Review 8.  Fluorescent contrast agents for tumor surgery.

Authors:  Qi Xiao; Tianming Chen; Shilin Chen
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.